| Autor: |
Bühler MM; Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hematopathology Section, Laboratory of Pathology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain., Lu J; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Scheinost S; Molecular Therapy in Hematology and Oncology, National Center for Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany., Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Madrid, Spain., Roos-Weil D; Gustave Roussy, INSERM U1170, Villejuif and Université Paris-Saclay Orsay, France., Hensel M; Mannheim Oncology Practice, Mannheim, Germany., Thavayogarajah T; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Moch H; Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland., Manz MG; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Haralambieva E; Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland., Marques Maggio E; Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland., Beà S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hematopathology Section, Laboratory of Pathology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Madrid, Spain., Giné E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Madrid, Spain; Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hematopathology Section, Laboratory of Pathology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Madrid, Spain., Bernard OA; Gustave Roussy, INSERM U1170, Villejuif and Université Paris-Saclay Orsay, France., Huber W; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Zenz T; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland. Electronic address: thorsten.zenz@usz.ch. |
Full Text from ScienceDirect